
The study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patients hospitalized with COVID-19, the WHO said on Thursday.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kgTeEd
via
IFTTT
0 comments:
Post a Comment